• Stephanie Bauler, Sophie Jacquin-Courtois, Julie Haesebaert, Jacques Luaute, Emmanuel Coudeyre, Corinne Feutrier, Benoit Allenet, Evelyne Decullier, Gilles Rode, and Audrey Janoly-Dumenil.
• Pôle de Rééducation et de Réadaptation Fonctionnelles, Hôpital Henry Gabrielle, Hospices Civils de Lyon, Saint Genis Laval, France.
• Eur. Neurol. 2014 Jan 1; 72 (5-6): 262-70.

ObjectiveTo describe the perceptions of French patients, caregivers and healthcare professionals on stroke and secondary preventive medications.MethodA qualitative study was conducted, based on four predetermined topics: stroke, secondary prevention medications, patient's experience, relationship between patient/caregiver and healthcare team.ResultsTwenty-six interviews were conducted. Difficulties in taking medications, lack of knowledge on stroke and medication benefits, fear of over medication were identified as barriers for adherence in patients. Doubts about generic drugs were expressed by caregivers. Healthcare professionals reported lack of knowledge and absence of clinical symptoms as barriers. On the other hand, support from caregivers and healthcare professional support is essential for compliance in all participants. Patients and caregivers expressed that fear of recurrence was a facilitator for treatment compliance.ConclusionThis study highlights the barriers and facilitators for stroke treatment adherence and underlines the similarities and differences between the perceptions of patients, caregivers and healthcare professionals. These results must be integrated into the future French educational programs to improve medication adherence.© 2014 S. Karger AG, Basel.

24 keywords...

hide…